These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3101915)

  • 21. Oestrogen and calcium homeostasis in women with hypoparathyroidism.
    McIlroy J; Dryburgh F; Hinnie J; Dargie R; Al-Rawi A
    BMJ; 1999 Nov; 319(7219):1252-3. PubMed ID: 10550094
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of progestins on bone metabolism in postmenopausal women.
    Mandel FP; Davidson BJ; Erlik Y; Judd HL; Meldrum DR
    J Reprod Med; 1982 Aug; 27(8 Suppl):511-4. PubMed ID: 7131444
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen and bone: osteoclasts take center stage.
    Novack DV
    Cell Metab; 2007 Oct; 6(4):254-6. PubMed ID: 17908554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.
    Selby PL; Peacock M
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1337-9. PubMed ID: 3098341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The minimum effective dose of estrogen for prevention of postmenopausal bone loss.
    Lindsay R; Hart DM; Clark DM
    Obstet Gynecol; 1984 Jun; 63(6):759-63. PubMed ID: 6374537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
    Stevenson JC
    Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women.
    Dogan E; Posaci C
    Postgrad Med J; 2002 Dec; 78(926):727-31. PubMed ID: 12509689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol and atherosclerosis: modulation by oestrogen.
    Barton M
    Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of the tissue selective estrogen complex (TSEC).
    Komm BS; Mirkin S
    J Cell Physiol; 2013 Jul; 228(7):1423-7. PubMed ID: 23359290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total bone calcium in normal women: effect of age and menopause status.
    Gallagher JC; Goldgar D; Moy A
    J Bone Miner Res; 1987 Dec; 2(6):491-6. PubMed ID: 3455633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Estrogens and aging in women].
    Warenik-Szymankiewicz A
    Pol Arch Med Wewn; 2001; 105 Suppl():105-10. PubMed ID: 12412230
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of estrogen dose on postmenopausal bone loss.
    Horsman A; Jones M; Francis R; Nordin C
    N Engl J Med; 1983 Dec; 309(23):1405-7. PubMed ID: 6633616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women.
    Huang AJ; Ettinger B; Vittinghoff E; Ensrud KE; Johnson KC; Cummings SR
    J Bone Miner Res; 2007 Nov; 22(11):1791-7. PubMed ID: 17620054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of hormones and endocrine diseases on bone tissue in adults].
    Holló I
    Orv Hetil; 1988 Jun; 129(26):1351-5. PubMed ID: 3292988
    [No Abstract]   [Full Text] [Related]  

  • 36. [Estrogens and postmenopausal osteoporosis].
    Linde J; Friis T; Ostergaard E
    Ugeskr Laeger; 1977 Jun; 139(26):1536-41. PubMed ID: 560074
    [No Abstract]   [Full Text] [Related]  

  • 37. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
    El Khoudary SR
    Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrinological status of postmenopausal osteoporosis.
    Nagant de Deuxchaisnes C; Devogelaer JP
    Clin Rheum Dis; 1986 Dec; 12(3):559-635. PubMed ID: 3078776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study.
    Golebiowski B; Badarudin N; Eden J; Gerrand L; Robinson J; Liu J; Hampel U; You J; Stapleton F
    Br J Ophthalmol; 2017 Jul; 101(7):926-932. PubMed ID: 27811278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Menopause and bone].
    Lobersztajn A; Trémollières F
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F28-32. PubMed ID: 23036315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.